为您找到相关结果约500个

你是不是要搜索 期刊asco头颈部 点击跳转

Assessing an ASCO Decision Aid for Improving the Accuracy and Attribution of Serious Adverse Event Reporting

Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines

Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive

Interpretation of the Results of the MINDACT Study and Consequent Recommendations in the Updated ASCO

PHYSICIANS: IS THERE CONVERGENCE BETWEEN VALUE ASSESSMENT BY ESMO, ASCO AND UK NICE DECISION?

Assessing the Clinical Value of Tumor Treating Fields for Newly Diagnosed GBM using the ASCO and ESMO

Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement

Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO

Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant

Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological

Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO

Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP

Establishing a Core Set of Performance Measures to Improve Value in Cancer Care: ASCO Consensus Conference

TREATMENT OF NON-METASTATIC MUSCLE-INVASIVE BLADDER CANCER: AUA/ASCO/ASTRO/SUO GUIDELINE (vol 198, pg

VALUE DEMONSTRATION OF IMMUNO-ONCOLOGY THERAPIES IN A RARE TUMOR COMPARING ASCO, NCCN, AND TRADITIONAL

为您找到相关结果约500个

共500条页码: 34/34页15条/页